Tysabri 300 MG/15 ML vial 15ML
Ended Awarded
- Contract number
- SPE2DX25F6XKV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $21,051
Award facts
- Contract value 100% obligated
- $21,051.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On June 16, 2025, the Defense Logistics Agency (DLA), operating under the Medical Supply Chain division, awarded a delivery order valued at $21,051.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This firm fixed-price delivery order, with an ultimate completion date of July 9, 2025, is for the supply of TYSABRI 300 mg/15 ml vials. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete openly in the federal procurement marketplace despite its small business status.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through November 2026. Under this comprehensive IDC vehicle, the DLA can issue firm fixed-price delivery orders for a broad range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support military healthcare facilities worldwide. DMS Pharmaceutical Group's established position as a critical supplier in the federal pharmaceutical supply chain, evidenced by its consistent award history with the DLA since 2001, has positioned it to fulfill specialized medical supply requirements such as this TYSABRI delivery to support Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DX25F6XKV?
SPE2DX25F6XKV was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on June 16, 2025.
How much is contract SPE2DX25F6XKV worth?
The government has obligated $21,051 on SPE2DX25F6XKV.
Is contract SPE2DX25F6XKV an order under another contract?
Yes. SPE2DX25F6XKV is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XKV competed?
The extent of competition for SPE2DX25F6XKV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award